CN106279207A - A kind of synthetic method of cefdinir - Google Patents
A kind of synthetic method of cefdinir Download PDFInfo
- Publication number
- CN106279207A CN106279207A CN201610663189.1A CN201610663189A CN106279207A CN 106279207 A CN106279207 A CN 106279207A CN 201610663189 A CN201610663189 A CN 201610663189A CN 106279207 A CN106279207 A CN 106279207A
- Authority
- CN
- China
- Prior art keywords
- cefdinir
- synthetic method
- reaction
- hydrogen chloride
- reactant liquor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960003719 cefdinir Drugs 0.000 title claims abstract description 66
- RTXOFQZKPXMALH-GHXIOONMSA-N cefdinir Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 RTXOFQZKPXMALH-GHXIOONMSA-N 0.000 title claims abstract description 64
- 238000010189 synthetic method Methods 0.000 title claims abstract description 25
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 20
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000000376 reactant Substances 0.000 claims abstract description 13
- 150000002148 esters Chemical class 0.000 claims abstract description 12
- 238000006482 condensation reaction Methods 0.000 claims abstract description 10
- 239000003054 catalyst Substances 0.000 claims abstract description 7
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical group COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 19
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 14
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 239000008346 aqueous phase Substances 0.000 claims description 11
- 239000007789 gas Substances 0.000 claims description 10
- GQLGFBRMCCVQLU-SVGQVSJJSA-N (6r,7r)-7-azaniumyl-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound S1CC(C=C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@H]21 GQLGFBRMCCVQLU-SVGQVSJJSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- 238000010511 deprotection reaction Methods 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 5
- 150000007530 organic bases Chemical class 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 239000013067 intermediate product Substances 0.000 abstract description 3
- 238000002955 isolation Methods 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- -1 Acyl cefdinir Chemical compound 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 0 CCC(C*C1C2*(C=N)C(C(Cc3c[s]c(*)n3)=N*)=*)=C(C(O)=O)N1C2=O Chemical compound CCC(C*C1C2*(C=N)C(C(Cc3c[s]c(*)n3)=N*)=*)=C(C(O)=O)N1C2=O 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Abstract
The present invention relates to the synthetic method of a kind of cefdinir; the method is with cefdinir parent nucleus 7 AVCA as raw material; itself and cefdinir pendant reactive ester generation condensation reaction is made to prepare the cefdinir of band protection group; reactant liquor without isolation, directly adds hydrogen chloride in reactant liquor and catalyst is sloughed protection group and prepared cefdinir.Intermediate product (cefdinir of band protection group) is the most first separated by the method, but directly carries out sloughing the reaction of protection group, and high yield obtains cefdinir, and yield is up to more than 85%, and this synthesis process route is short, the reagent low price of employing, low cost.
Description
Technical field
The invention belongs to biology,drug and chemical industry technology synthesis field, be specifically related to the synthetic method of a kind of cefdinir.
Background technology
Cefdinir is belonging to the third generation and wide spectrum cephalosporins is administered orally, and all has excellent to Grain-positive and gram-negative bacteria
Good antibacterial action, by the exploitation of Fujisawa Pharmaceutical of Japan, in October, 1991 lists.Chemistry entitled [6R-[6 α, 7 β
(Z)]]-7-[[(2-Amino-4-thiazolyl)-(hydroxyl imido) secondAcyl group] amino]-3-EthyleneBase-8-oxo-5-thia-1-
Azabicyclic [4.2.0]-2-octene-2-carboxylic acid.Molecular formula is C14H13N5O5S2, molecular weight is 395.42, and its structural formula is:
Cefdinir synthetic route the earliest is longer, and method is the most more.Owing to synthetic route is long, yield is low, the most relevant
Impurity is wayward, easily exceeds standard, and causes defective, and therefore cost is high, and various solvents and adjuvant in reaction are many, give back to
Receive and environment all brings bigger difficulty.
In prior art, as Chinese patent CN102010427A discloses the preparation method of a kind of cefdinir, the method
First 7-AVCA is carried out the silanization protection of carboxyl, then occurs with CAEM acylation reaction to obtain carboxyl and be silylated the second of protection
Acyl cefdinir, then will obtain acetyl cefdinir hexanamine salt by hydrolysis or alcoholysis and simple salt-forming reaction,
Again this salt hydrolysis is obtained cefdinir.It is with cefdinir parent nucleus 7-that prior art also discloses the synthetic method of cefdinir
After AVCA and pendant reactive ester condensation reaction, utilize p-methyl benzenesulfonic acid to carry out de-side chain again after becoming the method for salt or the separation that adds water and protect
After protecting base, carrying out crystallization and obtain cefdinir crude product, crude product is again through forming dicyclohexylamine complex or phosphoric acid composite etc., refined
Obtain cefdinir again.It is long all to there is synthetic route in above-mentioned synthetic method, high in cost of production defect.
Summary of the invention
The technical problem to be solved is to overcome the deficiencies in the prior art, it is provided that the conjunction of a kind of new cefdinir
One-tenth method.
For solving above technical problem, the present invention adopts the following technical scheme that
A kind of synthetic method of cefdinir, described synthetic method includes:
(1) make cefdinir parent nucleus 7-AVCA and cefdinir pendant reactive ester carry out condensation reaction and prepare band protection group
Cefdinir；
(2) catalyst and hydrogen chloride are added in the reactant liquor that step (1) obtains so that the cefdinir of band protection group enters
Row deprotection reaction, prepares cefdinir；
Wherein, the structural formula of described 7-AVCA as shown in formula I,
The structural formula of described cefdinir pendant reactive ester as shown in formula II,
R is
Further, in step (1), described condensation reaction is carried out in the presence of organic base and solvent, described organic base
For triethylamine or diethylamine, described solvent is the one in dimethyl formyl, dimethyl acetylamide, oxolane, acetonitrile or many
The combination planted, the reaction temperature of described condensation reaction is 5 DEG C～25 DEG C.
Further, the reactant liquor that step (1) obtains directly carries out next step reaction.
Further, in step (2), the reaction temperature of described deprotection reaction is-25 DEG C～0 DEG C, described catalyst
For methyl phenyl ethers anisole, described hydrogen chloride is hydrogen chloride gas.
Further, in step (2), in system, also add extractant, being embodied as of step (2): in step
(1) reactant liquor obtained adds extractant, methyl phenyl ethers anisole, at a temperature of-25 DEG C～0 DEG C, is passed through hydrogen chloride gas, carries out remove-insurance
Protect base reaction, after reaction terminates, prepare the reactant liquor containing cefdinir.
It is further preferred that after the deprotection reaction of step (2) terminates, at a temperature of 0 DEG C～25 DEG C, add alkali and adjust
Joint pH to 5.0～7.5, layering obtains aqueous phase, adds activated carbon decolorizing, filter in aqueous phase, and regulation filtrate pH is 2.0～3.5, knot
Crystalline substance, separates, is dried to obtain described cefdinir.
Specifically, described alkali be mass concentration be the aqueous slkali of 5%～10%, described aqueous slkali is NaHCO3、Na2CO3、
K2CO3Or KHCO3In one.
Specifically, the aqueous phase that described layering obtains is before adding activated carbon decolorizing process, by dichloromethane or acetic acid second
Ester back extraction.
Specifically, the reactant liquor containing cefdinir that step (2) obtains is first in system before being for further processing
In be passed through N2The hydrogen chloride being dissolved in system with removal.
Specifically, described activated carbon decolorizing temperature is 5 DEG C～25 DEG C.
It is further preferred that described extractant is dichloromethane or ethyl acetate.
Due to the enforcement of technique scheme, the present invention compared with prior art has the advantage that
The synthetic method of the cefdinir of the present invention, after the method condensation reaction, reactant liquor is without isolation, directly in reaction
Liquid adds hydrogen chloride and catalyst is sloughed protection group and prepared cefdinir.The method the most first by intermediate product (band protection group
Cefdinir) separate, but directly carry out sloughing the reaction of protection group, high yield obtains cefdinir, is initial with 7-AVCA
Raw material calculates, and total recovery is up to more than 85%, and this synthesis process route is short, products obtained therefrom quality good (impurity is lower), adopts
Reagent low price, low cost, it is easy to industrialized production.
Detailed description of the invention
The route that the synthetic method of cefdinir of the present invention uses is: with cefdinir parent nucleus 7-AVCA as initiation material,
In organic solvent, under the conditions of organic base catalytic, carry out condensation reaction with cefdinir pendant reactive ester, obtain band protection group
Cefdinir, form intermediate product without isolation, but be directly added into methyl phenyl ethers anisole catalyst, be passed through dry hydrogen chloride gas,
Slough protection group and obtain cefdinir, then allow the cefdinir in system form sodium salt or potassium salt separates with organic facies, aqueous phase
After purified decolouring, acid adding, crystallization, separate, be dried to obtain cefdinir.Wherein, described setting-up point 5 DEG C～20
DEG C, be passed through dry hydrogen chloride gas temperature and be-25 DEG C～0 DEG C, add the temperature of alkali be 0 DEG C～25 DEG C, pH value be 5.0～7.5.
Below in conjunction with specific embodiment, the invention will be further described.
Embodiment 1
The present embodiment provides the synthetic method of a kind of cefdinir, the cefdinir pendant reactive ester used in this embodiment
Meet molecular formula shown in formula II, and R is
Synthetic method particularly as follows: in dry reaction bulb, adds 30g 7-AVCA, 85g cefdinir pendant reactive ester,
100mL dimethyl acetylamide, temperature control 15 DEG C～20 DEG C, drip 30g triethylamine, stirring reaction 4h, to react complete molten clearly, reaction
After end, add 250mL dichloromethane, be cooled to-15 DEG C～-10 DEG C, add 50mL methyl phenyl ethers anisole, be passed through dry hydrogen chloride gas
After body, about 2h, HPLC measured reaction terminal, after reaction terminates, logical N2Drive the hydrogen chloride gas of excess in system away.It is subsequently adding
100mL H2O, the Na of dropping 10%2CO3Solution, adjusting pH value is 5.5～6.0, and temperature control is less than 5 DEG C, layering.Aqueous phase adds
100mL CH2Cl2Extraction, layering, aqueous phase adds 3g activated carbon decolorizing, filters, add 500mL water, use 2mol/L salt after decolouring 1h
Acid adjust pH value to 2.2～2.4, temperature control 20 DEG C～25 DEG C, after growing the grain 2h filter, washing, ethanol wash, be dried, obtain cephalo ground
Buddhist nun 45g, yield 85.8%, purity is >=99%.
Embodiment 2
The present embodiment provides the synthetic method of a kind of cefdinir, the cefdinir pendant reactive ester used in this embodiment
Meet molecular formula shown in formula II, and R is
Synthetic method is particularly as follows: in dry reaction bulb, add 22.6g 7-AVCA, 43g cefdinir pendant reactive
Ester, 150mL oxolane, temperature control 20 DEG C～23 DEG C, drip 12g triethylamine, stirring reaction 5h, HPLC measured reaction terminal, reaction
Add 200mL dichloromethane, methyl phenyl ethers anisole 30mL after end, lower the temperature-25 DEG C～-20 DEG C, be passed through dry hydrogen chloride gas, about
After 1.5h, HPLC measured reaction terminal.After reaction terminates, logical N2Driving the hydrogen chloride gas of excess in system away, temperature control is less than 0
DEG C, the K of dropping 5%2CO3, control ph is 5.5～6.0, layering, adds 80mLCH in aqueous phase2Cl2Extraction, layering, in aqueous phase
Add 2g activated carbon decolorizing 1h, filter, add water 400mL, with 2mol/L hydrochloric acid adjust pH value to 2.2～2.4, temperature control 25 DEG C～28
DEG C, filtering after growing the grain 2h, washing, ethanol wash, be dried, obtain cefdinir 35g, yield 88.6%, purity is 99.2%.
Above the present invention is described in detail, its object is to allow the personage being familiar with this art will appreciate that this
Invention content and be carried out, can not limit the scope of the invention with this, and the invention is not restricted to above-mentioned enforcement
Example, all equivalence changes made according to the spirit of the present invention or modification, all should contain within protection scope of the present invention.
Claims (10)
1. the synthetic method of a cefdinir, it is characterised in that: described synthetic method includes:
(1) make cefdinir parent nucleus 7-AVCA and cefdinir pendant reactive ester carry out condensation reaction and prepare the cephalo of band protection group
Ground Buddhist nun；
(2) catalyst and hydrogen chloride are added in the reactant liquor that step (1) obtains so that the cefdinir of band protection group takes off
Protection group is reacted, and prepares cefdinir；
Wherein, the structural formula of described 7-AVCA as shown in formula I,
The structural formula of described cefdinir pendant reactive ester as shown in formula II,
R is
The synthetic method of cefdinir the most according to claim 1, it is characterised in that: in step (1), described condensation reaction
Carrying out in the presence of organic base and solvent, described organic base is triethylamine or diethylamine, described solvent be dimethyl formyl, two
The combination of one or more in methylacetamide, oxolane, acetonitrile, the reaction temperature of described condensation reaction is 5 DEG C～25
℃。
The synthetic method of cefdinir the most according to claim 1, it is characterised in that: the reactant liquor that step (1) obtains is straight
Tap into next step reaction of row.
The synthetic method of cefdinir the most according to claim 1, it is characterised in that: in step (2), described Deprotection
The reaction temperature of reaction is-25 DEG C～0 DEG C, and described catalyst is methyl phenyl ethers anisole, and described hydrogen chloride is hydrogen chloride gas.
5. according to the synthetic method of the cefdinir described in claim 1 or 4, it is characterised in that: in step (2), also in system
Middle addition extractant, being embodied as of step (2): add extractant, methyl phenyl ethers anisole in the reactant liquor that step (1) obtains, in-
It is passed through hydrogen chloride gas at a temperature of 25 DEG C～0 DEG C, carries out deprotection reaction, after reaction terminates, prepare containing cefdinir
Reactant liquor.
The synthetic method of cefdinir the most according to claim 5, it is characterised in that: the deprotection reaction of step (2)
After end, at a temperature of 0 DEG C～25 DEG C, adding alkali regulation pH to 5.0～7.5, layering obtains aqueous phase, adds activated carbon in aqueous phase
Decolouring, filters, and regulation filtrate pH is 2.0～3.5, and crystallization separates, is dried to obtain described cefdinir.
The synthetic method of cefdinir the most according to claim 6, it is characterised in that: described alkali be mass concentration be 5%
～the aqueous slkali of 10%, described aqueous slkali is NaHCO3、Na2CO3、K2CO3Or KHCO3In one.
The synthetic method of cefdinir the most according to claim 6, it is characterised in that: the aqueous phase that described layering obtains is adding
Before entering activated carbon decolorizing process, with dichloromethane or ethyl acetate back extraction.
The synthetic method of cefdinir the most according to claim 6, it is characterised in that: step (2) obtain containing cephalo
The reactant liquor of ground Buddhist nun was first passed through N before being for further processing in system2The hydrogen chloride being dissolved in system with removal.
The synthetic method of cefdinir the most according to claim 5, it is characterised in that: described extractant is dichloromethane
Or ethyl acetate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610663189.1A CN106279207A (en) | 2016-08-15 | 2016-08-15 | A kind of synthetic method of cefdinir |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610663189.1A CN106279207A (en) | 2016-08-15 | 2016-08-15 | A kind of synthetic method of cefdinir |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106279207A true CN106279207A (en) | 2017-01-04 |
Family
ID=57669975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610663189.1A Pending CN106279207A (en) | 2016-08-15 | 2016-08-15 | A kind of synthetic method of cefdinir |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106279207A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108002966A (en) * | 2017-12-11 | 2018-05-08 | 苏州大学 | A kind of method of synthesis 1,2- diarylethane class compounds |
| CN110759933A (en) * | 2019-10-30 | 2020-02-07 | 广州牌牌生物科技有限公司 | Preparation method of cefdinir impurity G |
| CN111072687A (en) * | 2020-03-03 | 2020-04-28 | 刘方涛 | Preparation method of cefdinir |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040242557A1 (en) * | 2003-06-02 | 2004-12-02 | Ramesh Dandala | Process for preparing cefdinir |
| CN1628118A (en) * | 2002-04-26 | 2005-06-15 | 兰贝克赛实验室有限公司 | Process for prepn. of cefdinir |
| WO2005121154A1 (en) * | 2004-06-08 | 2005-12-22 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of cefdinir |
| WO2007053723A2 (en) * | 2005-10-31 | 2007-05-10 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of cefdinir |
| EP1842852A1 (en) * | 2002-08-13 | 2007-10-10 | Sandoz AG | A cefdinir intermediate |
| CN101362769A (en) * | 2007-08-06 | 2009-02-11 | 艾斯.多伯法股份公司 | Synthetic method of cefdinir |
| CN101565427A (en) * | 2009-06-11 | 2009-10-28 | 浙江昂利康制药有限公司 | Preparation method of cefdinir |
| CN101974020A (en) * | 2010-11-19 | 2011-02-16 | 苏州中联化学制药有限公司 | Method for synthesizing cefdinir |
| CN102659817A (en) * | 2012-05-08 | 2012-09-12 | 浙江普洛得邦制药有限公司 | Preparation method of cefdinir |
-
2016
- 2016-08-15 CN CN201610663189.1A patent/CN106279207A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1628118A (en) * | 2002-04-26 | 2005-06-15 | 兰贝克赛实验室有限公司 | Process for prepn. of cefdinir |
| EP1842852A1 (en) * | 2002-08-13 | 2007-10-10 | Sandoz AG | A cefdinir intermediate |
| US20040242557A1 (en) * | 2003-06-02 | 2004-12-02 | Ramesh Dandala | Process for preparing cefdinir |
| WO2005121154A1 (en) * | 2004-06-08 | 2005-12-22 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of cefdinir |
| WO2007053723A2 (en) * | 2005-10-31 | 2007-05-10 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of cefdinir |
| CN101362769A (en) * | 2007-08-06 | 2009-02-11 | 艾斯.多伯法股份公司 | Synthetic method of cefdinir |
| CN101565427A (en) * | 2009-06-11 | 2009-10-28 | 浙江昂利康制药有限公司 | Preparation method of cefdinir |
| CN101974020A (en) * | 2010-11-19 | 2011-02-16 | 苏州中联化学制药有限公司 | Method for synthesizing cefdinir |
| CN102659817A (en) * | 2012-05-08 | 2012-09-12 | 浙江普洛得邦制药有限公司 | Preparation method of cefdinir |
Non-Patent Citations (3)
| Title |
|---|
| 叶连宝 等: ""头孢地尼的合成工艺研究"", 《中国抗生素杂志》 * |
| 张静 等: ""活性硫酯法制备头孢地尼新工艺"", 《中国抗生素杂志》 * |
| 汤有坚 等: ""头孢地尼的绿色合成工艺"", 《浙江化工》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108002966A (en) * | 2017-12-11 | 2018-05-08 | 苏州大学 | A kind of method of synthesis 1,2- diarylethane class compounds |
| CN110759933A (en) * | 2019-10-30 | 2020-02-07 | 广州牌牌生物科技有限公司 | Preparation method of cefdinir impurity G |
| CN111072687A (en) * | 2020-03-03 | 2020-04-28 | 刘方涛 | Preparation method of cefdinir |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110642897B (en) | Preparation method of beta-nicotinamide riboside chloride | |
| CN103539803B (en) | A kind of method preparing ceftriaxone sodium | |
| CN105622535B (en) | A kind of preparation method of LCZ696 | |
| US11420948B2 (en) | Synthesis method for cariprazine | |
| CN102395591B (en) | Method for preparing prasugrel | |
| CN106279207A (en) | A kind of synthetic method of cefdinir | |
| CN108727411A (en) | A kind of preparation method of cefotiam hydrochloride | |
| CN102952088A (en) | Preparation method of dexrazoxane | |
| CN104402909A (en) | Synthetic method of cefoxitin acid | |
| CN102633819A (en) | Preparation method of cefoxitin | |
| US8609834B2 (en) | Method for synthesizing sucrose-6-acetic ester | |
| CN110551144B (en) | Preparation method of amoxicillin | |
| CN104193766A (en) | Method for preparing cefetamet acid | |
| CN110407857B (en) | Preparation process of cefathiamidine | |
| CN108358979B (en) | Purification method of tulathromycin | |
| CN102010432B (en) | Cefodizime sodium compound and novel method thereof | |
| CN110590812A (en) | Preparation method of cefminox sodium | |
| CN110128449A (en) | 7- phenylacetyl amido -3- desacetoxycephalosporanic acid salt and its preparation method and application | |
| CN115093431A (en) | A kind of method of synthesizing cefpodoxime axetil | |
| CN113735792A (en) | Preparation method of chlorphenamine and intermediate thereof | |
| CN102234289B (en) | Novel method for preparing ceftiofur intermediate | |
| CN106478666A (en) | The preparation method of 7 amino, 3 methoxyl methyl, 3 cephem 4 carboxylic acid | |
| CN105254650A (en) | Synthesis method of antibacterial drug cefoxitin | |
| CN104672239A (en) | Process for preparing abacavir intermediate in formula V by adopting one-pot method | |
| CN115925702B (en) | A purification method of imidazo[4,5-C]pyridine derivatives and imidazo[4,5-C]pyridine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170104 |